These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22930318)

  • 1. Effective control of recalcitrant pruritus by bevacizumab: a possible role for vascular endothelial growth factor in chronic itch?
    Krause K; Krull C; Kessler B; Lange-Asschenfeldt B; Maurer M; Metz M
    Acta Derm Venereol; 2013 Mar; 93(2):175-9. PubMed ID: 22930318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hemicorporal prurigo related to a posttraumatic Brown-Séquard syndrome.
    Thielen AM; Vokatch N; Borradori L
    Dermatology; 2008; 217(1):45-7. PubMed ID: 18367840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
    Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
    N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
    Tanis R; Ferenczi K; Payette M
    J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review.
    Almustafa ZZ; Weller K; Autenrieth J; Maurer M; Metz M
    Acta Derm Venereol; 2019 Sep; 99(10):905-906. PubMed ID: 31233177
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulating Agents as Antipruritics.
    Erickson S; Nahmias Z; Rosman IS; Kim BS
    Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itch Management: Treatments under Development.
    Pereira MP; Ständer S
    Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of prurigo nodularis with topical capsaicin.
    Ständer S; Luger T; Metze D
    J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
    Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
    J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prurigo simplex subacuta or prurigo simplex acuta?
    Akar HH; Tahan F; Balkanli S; Sadet Özcan S
    Eur Ann Allergy Clin Immunol; 2014 Jul; 46(4):152-3. PubMed ID: 25053633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dupilumab in prurigo nodularis in elderly patient.
    Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
    Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.
    Saraceno R; Chiricozzi A; Nisticò SP; Tiberti S; Chimenti S
    J Dermatolog Treat; 2010 Nov; 21(6):363-6. PubMed ID: 20536273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L; Rachelska G; Nedelec B
    Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
    Meyer N; Paul C; Misery L
    Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients.
    Krull C; Schoepke N; Ohanyan T; Brachaczek M; Maurer M; Lange-Asschenfeldt B; Metz M
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1357-61. PubMed ID: 26446750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
    Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
    Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
    Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
    Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
    Maurer T; Poncelet A; Berger T
    Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
    Ameglio F; D'Auria L; Cordiali-Fei P; Mussi A; Valenzano L; D'Agosto G; Ferraro C; Bonifati C; Giacalone B
    J Biol Regul Homeost Agents; 1997; 11(4):148-53. PubMed ID: 9582615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Recalcitrant Prurigo with Alitretinoin.
    Gadaldi K; Erdemoğlu Y; Yawalkar N
    Dermatology; 2015; 231(4):330-3. PubMed ID: 26304762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.